US2009012267A1PendingUtilityA1

Anti-hydroxylase antibodies and uses thereof

Assignee: MASSACHUSETTS INST TECHNOLOGYPriority: Nov 14, 2003Filed: Mar 25, 2008Published: Jan 8, 2009
Est. expiryNov 14, 2023(expired)· nominal 20-yr term from priority
C07K 16/40G01N 2500/00C07K 2317/565A61P 35/00C07K 2317/76C07K 2317/21C07K 2317/622G01N 33/57557
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Antibodies, or antigen-binding portions thereof, to aspartyl (asparaginyl) β-hydroxylase are provided. The anti-aspartyl (asparaginyl) β-hydroxylase antibodies, or antigen-binding portions thereof, can modulate activity of aspartyl (asparaginyl) β-hydroxylase.

Claims

exact text as granted — not AI-modified
1 . A composition comprising an isolated human antibody or a fragment or other variant thereof, wherein the antibody, the fragment, or the other variant specifically binds to an aspartyl (asparaginyl) β-hydroxylase (AAH). 
     
     
         2 .- 35 . (canceled)

Join the waitlist — get patent alerts

Track US2009012267A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.